Vanderbilt Medical Laboratories has implemented in-house rapid antigen testing for histoplasmosis, reducing turnaround times and improving patient management, according to clinical staff and recent case reports.
In silico analysis of 3,900 influenza sequences shows comparable sensitivity for the test against the subclade K variant currently circulating.
The multiplex PCR assay achieved 100% accuracy while reducing turnaround time for histoplasmosis, blastomycosis, and coccidioidomycosis diagnosis.
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
Molecular sensor releases thyme flavor when encountering influenza virus, potentially enabling at-home screening through gum or lozenges.
Deep-learning model trained on 4,000 samples shows 98.6% agreement with manual review while identifying additional organisms missed by technologists.
The test uses Abbott's simpli-COLLECT platform to detect chlamydia, gonorrhea, trichomonas, and mycoplasma genitalium from patient-collected specimens.